EUDA Health Holdings Ltd. Files March 2024 6-K Report

TL;DR

EUDA Health (formerly 8i Acquisition 2 Corp.) filed its March 6-K, confirming 20-F annual filings.

AI Summary

EUDA Health Holdings Ltd. filed a Form 6-K on April 4, 2024, for the month of March 2024. The company, formerly known as 8i Acquisition 2 Corp., is reporting as a foreign private issuer. The filing provides information regarding its principal executive offices in Singapore and confirms it files annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for investors on EUDA Health Holdings Ltd.'s reporting status and corporate information, including its transition from its former name.

Risk Assessment

Risk Level: low — This is a routine reporting form (6-K) that does not contain significant new financial or operational information.

Key Players & Entities

• EUDA Health Holdings Ltd (company) — Registrant
• 8i Acquisition 2 Corp. (company) — Former company name
• April 4, 2024 (date) — Filing date
• March 2024 (date) — Reporting period
• Form 20-F (document) — Annual report form
• Form 6-K (document) — Report type

FAQ

Key Financial Figures

• $1.275 — based on the per share closing price of $1.275 as of March 14, 2024) in full satisfact
• $212,483.96 — March 14, 2024) in full satisfaction of $212,483.96 of salaries and other compensation owed
• $95,700.05 — March 14, 2024) in full satisfaction of $95,700.05 of salaries and other compensation owed
• $68,403.25 — March 14, 2024) in full satisfaction of $68,403.25 of salaries and other compensation owed
• $22,500 — of the Company, an aggregate amount of $22,500, or a total of $24,004.11 with unpaid a
• $24,004.11 — regate amount of $22,500, or a total of $24,004.11 with unpaid and accrued interests at 8%
• $180,000 — agreed to pay 8iEPL for a total sum of $180,000 for such advisory services (the “
• $712,253 — rowed from 8iEPL an aggregate amount of $712,253.72, or a total of $731,372.52 with unpa
• $731,372.52 — te amount of $712,253.72, or a total of $731,372.52 with unpaid and accrued interests at 8%
• $911,372.52 — ertible note in the aggregate amount of $911,372.52 (the “8iEPL Convertible Note&rdqu
• $1.27 — into ordinary shares of the Company at $1.27 per share (the “Conversion Shares
• $250,000 — e Company received the first tranche of $250,000 from Gilandi on January 17, 2024 under
• $500,000 — Loan Agreement, an aggregate amount of $500,000 of the loan automatically converted int
• $1.00 — the Company’s ordinary shares at $1.00 per share on March 31, 2024, and the Co

Filing Documents

• form6-k.htm (6-K) — 30KB
• ex10-1.htm (EX-10.1) — 1KB
• ex10-2.htm (EX-10.2) — 1KB
• ex10-3.htm (EX-10.3) — 1KB
• ex10-4.htm (EX-10.4) — 38KB
• ex10-5.htm (EX-10.5) — 66KB
• ex10-6.htm (EX-10.6) — 67KB
• ex10-1_001.jpg (GRAPHIC) — 308KB
• ex10-1_002.jpg (GRAPHIC) — 54KB
• ex10-2_001.jpg (GRAPHIC) — 310KB
• ex10-2_002.jpg (GRAPHIC) — 51KB
• ex10-3_001.jpg (GRAPHIC) — 299KB
• ex10-3_002.jpg (GRAPHIC) — 53KB
• 0001493152-24-013112.txt ( ) — 1689KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: April 4, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR